Medical Research

CRISPR, Gene Editing and IVF

FertilityIQ: Paula, great to have you back! You've had a busy month so catch us up on CRISPR and the data you just released?

Paula Amato: Good to be back and glad to see the site is growing! OK, so CRISPR is a gene-editing tool that acts like a molecular scissors to induce cuts in the DNA of an embryo at a targeted location. We used CRISPR to correct a disease-causing gene mutation in viable human embryos. The gene we targeted is called MYBPC3. A mutation in the MYBPC3 gene is one of the most common causes of a heart condition called hypertrophic cardiomyopathy (HCM), which can lead to sudden cardiac death in young people.

FertilityIQ: Sounds critical. So our community is trying to have a healthy baby. This is relevent to them, right?

Paula Amato: Yes, indeed. This technology, if eventually proven safe and effective, could theoretically prevent the transmission of serious genetic diseases from parents to their children and future generations. We'd use this in conjunction with PGD, which is out and available today.

FertilityIQ: Got it. So we have people on our site that are fearful about all sorts of challenges their offspring might have: psychiatric, endocrine, and on. Is this likely to help one disease state specifically?

Paula Amato: Theoretically it could be applied to any of the thousands of heterozygous (embryo has one normal copy and one abnormal copy of the gene) genetic diseases caused by single gene mutations.

FertilityIQ: A lot of our community already has frozen embryos. Could this tool one day be applied to embryos they've previously stored?

Paula Amato: It's pretty unlikely. An important finding of our study was that in order to overcome the issue of mosacism (a mixture of genetically normal and abnormal cells in the embryos), the CRISPR construct needed to be introduced into the egg at the same time as sperm injection (or ICSI).

FertilityIQ: So this is more on a "go-forward" basis. Any other misconceptions or questions we should sort out?

Paula Amato: That this will lead to so-called "designer babies" and eugenics. The National Academy of Sciences, and we agree, explicitly states that genetic modification should not be used for enhancement purposes because of the serious ethical concerns. Furthermore, we don't know which genes are responsible for traits like intelligence and it is likely to be many genes. If the repair mechanism we describe in our study holds true (i.e. the embryo appeared to use the normal copy of the gene from the other parent as a template to repair itself rather than the externally provided synthetic DNA template) it would also be difficult to replace an existing gene allele with a more desirable gene allele.

FertilityIQ: With misconceptions come roadblocks, atleast in our experience. What stands in the way of this actually getting used in the states?

Paula Amato: The two main barriers in the U.S. are lack of federal funding available for human embryo research and a law that prohibits the FDA from considering any applications for clinical trials involving genetic modification.

FertilityIQ: Let's say you overcome those, from an affordability standpoint, what are we talking? When something new hits the fertility market, the price is normally excruciating.

Paula Amato: I imagine it would incrementally increase the cost of IVF and PGD. As we know, IVF is expensive and not accessible to everyone in this country. This type of technology, if it continues to not be covered by insurance as in most cases, may exacerbate those inequities, and that is one of the many ethical concerns.

FertilityIQ: If a patient decided they wanted to help further the research, any suggestions?

Paula Amato: Lobby our government officials to allow NIH funding for human embryo research and the FDA to review applications for clinical trials related to this technology. Otherwise, I'm afraid the technology will advance in other countries with perhaps less strict regulatory oversight with potentially deleterious consequences. We should begin a transparent public discourse about the ethical issues and establish some international guidelines regarding germline gene editing.

FertilityIQ: OK, we'll get out your hair and let you get back to it. Can't thank you enough.

Paula Amato: Anytime, hope this helps! Come see us in Portland!

Expert's Perspective
Dr de Ziegler's Guide To Endometriosis

Dr. de Ziegler breaks down the misconceptions around surgery being the only way to diagnose endometriosis, weighs in on the decision between IVF and endometriosis surgery, and much more.

Expert's Perspective
When Is The ERA Test Appropriate?

The Endometrial Receptivity Assay is a test used by clinicians to discern when an embryo should be transferred to the uterus. The developmental state of the embryo and the uterine lining must be in sync for the embryo to implant. Here we look at the theory behind the ERA's usefulness and what the data implies about who, if anyone, should have the test performed.

Expert's Perspective
Treating East Asian Women For Infertility

East Asian women may metabolize estorgen differently and this may be the reason their rates of success tend to lag those of Caucasian women. This may add insight on the woman's choice of a fresh versus frozen transfer or how much gonadatropins to take.

Expert's Perspective
How We Might Treat South Asian Women Differently

As a field we're beginning to appreciate that women of different ethnicities may require unique treatment to achieve comparable outcomes. Here, Stanford professor Val Baker eluciates some of the nuances in treating women of a South Asian background.

Expert's Perspective
How Long Are Frozen Eggs and Embryos Good For?

IVF treatment is a relatively new treatment, and egg and embryo freezing are newer still. So do we know how long these gametes can be safely stored and still work?

Expert's Perspective
The Male Fertility Evaluation: Enhances Options and Signals of Future Health

20 - 25% of U.S. couples annually undergo IVF without having the male partner properly checked. This drives tens of thousands of unnecssary treatments, as well as needless cost and suffering. What's more, bypassing this crucial step causes us to miss a vital signal into that man's future health.

Expert's Perspective
Is it safe to ship cryopreserved eggs (and embryos)?

Patients are increasingly eager to ship their eggs and embryos to clinics out of town, out of state and out of the country. Vitrification has made that a far more delicate process. Peter Nagy, Ph.D helps explain the outcomes, steps and costs associated with shipping gametes from one clinic to another.

Expert's Perspective
Freeze Eggs or Embryos?

When the option to freeze embryos is available to patients, many disregard the option to freeze eggs. Owen Davis, ASRM President, weighs in on why egg freezing is still an important option to consider.

Expert's Perspective
From MacBooks to MAC Cosmetics: How Our Daily Routine Impacts Fertility

Dr. Cooper lays out the evidence on the products & habits that harm fertility, and realistic steps we can take to protect ourselves

Expert's Perspective
Improving IVF Success Rates: Using Low Oxygen in the Lab

Selecting a clinic is as much about selecting their laboratory as anything else. A key determinant of lab quality is the conditions they use to culture embryos. Using low oxygen in the incubator is preferable, yet a third of laboratories don't do this.

Expert's Perspective
Early Pregnancy Loss

Early pregnancy loss is the only focus of the team at Montefiore-Einstein in NYC. Here are some of their high-level observations on how to deal with the medical challenges.

+ Show More Articles
Personal Story
Why I Didn't Choose Reproductive Immunology After Miscarriage

After undergoing IVF for secondary infertility, Elissa was blindsided by a miscarriage of a PGS-tested normal embryo. She kept reading online about immunological causes and treatments, so she used her background in reporting to get to the bottom of the treatments behind the chatroom hype.

Personal Story
What We Never Expected About Reciprocal IVF

Christina and her wife Katie decided to bulid their family using Reciprocal IVF. Christina walks us through what turned out how they expected, and what didn't -- including the financial costs, choosing sperm donors, IVF success (and failure), recognition by the state, and having the outside world accept them as equal mothers.

Personal Story
Getting it Together After the Diagnosis: Making a Plan With Your Partner

Laura and her wife Sam always presumed they would need treatment to have a child, but the news Laura had fertility issues came as a surprise. Over the course of multiple cycles, and multiple years, they learned a number of crucial lessons.

Personal Story
Marriage & Male Infertility: Not on the Same Page and That’s O.K.

Men and women often deal differently with the emotional impact of infertility. How important is it for us to see everything the same way?

Personal Story
Twiblings: Being Pregnant During Surrogacy

Some hopeful mothers fear that having a child through surrogacy will be less special or intimate. For those who wonder, meet Nancy Rohde, who carried her own child, and had a baby through surrogacy, at the same time.

Personal Story
Wrangling With Reduction

Many patients undergoing fertility treatment ultimately need to grapple with the notion of whether it is safe to have a multiple pregnancy. Katie Ferraro talks about her decision not to selectively reduce during her quadruplet pregnancy.

+ Show More Articles
Medical Research
What Mosaicism Means for Live Birth Rates

New data compare results transferring different types of mosaic embryos, with surprising outcomes.

Medical Research
IUI Success Rates Doubled With Endometrial Scratch

Medicated IUI success rates remain stubbornly low with live birth rates often around 10% per cycle. Investigators determined whether incorporating endometrial scratch bolsters IUI success rates. For the moment, it appears so.

Medical Research
The Impact of Sugar, Soda and Caffeine on IVF

The team at Brigham & Women's Hospital in Boston reveals surprising results on how sugar, soda and caffeine each impact (or don't) oocyte numbers and ultimate IVF success rates.

Medical Research
The best starting point in treating PCOS? It’s not Clomid.

PCOS is responsible for 80% of cases where a woman isn't ovulting. A new study compared pregnancy success of clomiphene citrate (clomid) vs. letrozole (femara), with some strong results.

Medical Research
Weight Loss and IVF

The average American woman has a BMI in the high 20's. So for women undergoing IVF, with a BMI in the low-mid 30's, does weight loss improve rates of success? A team from Sweden ran a thoughtfully-conducted trial that offers up surprisingly complex answers.

Medical Research
IUI or IVF For Unexplained Infertility

Roughly 30% of infertility cases are labeled "unexplained," so how should patients decide between IUI vs IVF when we don't know the underlying issue? Here's one clue for a narrow subset of the newly-diagnosed "unexplained" population.

Medical Research
Does Your Clinic Influence If Your Embryos Are Good

Theoretically, the quality of your eggs and sperm should determine the quality of your embryos. However, this month we're reviewing data that shows which clinic you go to, and how they care for you and your embryos, could be a crucial determinant.

Medical Research
When IVF Babies Grow Up, Are They Healthy?

An Israeli study rigorously followed up with adults who were conceived via IVF, and compared their cognitive function, medical and mental health with naturally conceived peers. This is a unique study focusing on the long-term health of IVF babies and adults.

Medical Research
When One IVF Cycle Completes All Your Family Building Goals

For some IVF patients a single cycle can deliver two children through two pregnancies. For many Americans, two children is the ideal number. So who are the best candidates for "one-and-done" IVF in a safe and responsible manner?

Medical Research
Why It Matters Which Doctor Performs Your IVF Transfer

According to FertilityIQ data, 70% of patients have a different doctor perform their transfer. Scott Morin and Eric Forman of RMA New Jersey study to what extent that matters.

+ Show More Articles